<DOC>
	<DOCNO>NCT03057951</DOCNO>
	<brief_summary>The aim study evaluate efficacy safety empagliflozin versus placebo top guideline-directed medical therapy patient heart failure preserve ejection fraction</brief_summary>
	<brief_title>EMPagliflozin outcomE tRial Patients With chrOnic heaRt Failure With Preserved Ejection Fraction ( EMPEROR-Preserved )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Empagliflozin</mesh_term>
	<criteria>Inclusion criterion : Male female patient , age &gt; = 18 year screen . For Japan : Age &gt; =20 year screen Patients chronic HF ( Chronic Heart Failure ) NYHA ( New York Heart Association classification ) class IIIV preserve EF ( Ejection Fraction ) ( LVEF ( Left Ventricular Ejection Fraction ) &gt; 40 % ) elevate NTproBNP ( Nterminal prohormone brain natriuretic peptide ) &gt; 300 pg/ml patient without AF , OR &gt; 900 pg/ml patient AF , analyse Central laboratory Visit 1 Structural heart disease within 6 month prior Visit 1 , OR document HHF ( Hospitalisation Heart Failure ) within 12 month prior Visit 1 Stable dose oral diuretic , prescribe Signed date write ICF ( informed consent form ) Further inclusion criterion apply Exclusion criterion : Myocardial infarction , coronary artery bypass graft surgery major cardiovascular surgery , stroke TIA ( Transient Ischaemic Attack ) past 90 day prior Visit 1 Heart transplant recipient list heart transplant Acute decompensated HF ( Heart Failure ) Systolic blood pressure ( SBP ) &gt; = 180 mmHg Visit 2 . Symptomatic hypotension and/or SBP &lt; 100 mmHg Indication liver disease , Impaired renal function , define eGFR ( Estimated Glomerular Filtration Rate ) &lt; 20 mL/min/1.73 m2 ( CKDEPI ( Chronic Kidney Disease Epidemiology Collaboration Equation ) ) cr require dialysis History ketoacidosis Treatment SGLT ( Sodiumglucose cotransporter ) 2 inhibitor combine SGLT1 2 inhibitor Currently enrol another investigational device drug trial Known allergy hypersensitivity empagliflozin SGLT2 inhibitor Women pregnant , nursing , plan become pregnant trial Further exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>